Bliss GVS Pharma Limited (BLISSGVS) — Announcement
· NSE
🔴 High Importance
Neutral
No summary available
About Bliss GVS Pharma Limited (BLISSGVS)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹2,937.23 Cr
P/E: 49.0
📡 Get AI alerts when BLISSGVS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BLISSGVS — Free💡 Ask AI about this filing
"How does this affect BLISSGVS margins?"
"Compare with last quarter results"
"What should investors watch for?"
Ask AI Free →
📊 More BLISSGVS filings
- 🟡 Board Meeting — 3 July 2026 The board approved the appointment of Santosh Parab as an additional non-executive director effectiv...
- 🟡 Board Meeting — 3 July 2026 Bliss GVS Pharma announced board approval of three key changes: appointment of Santosh Parab as Addi...
- 🟡 Board Meeting — 3 July 2026 Bliss GVS Pharma announced board approval of three key leadership changes effective July 2026: appoi...
- 🟡 Board Meeting — 3 July 2026 No summary available
- Financial Results — 29 June 2026 Bliss GVS Pharma Limited announced that its trading window closes on July 1, 2026, ahead of the unau...
🔥 Also filed on 24 June 2026
RKEC
RKEC Projects Limited
Announcement
LAXMIINDIA
Laxmi India Finance Limited
Announcement
NETWORK18
Network18 Media & Investments Limited
Announcement
VINEETLAB
Vineet Laboratories Limited
Announcement
BANDHANBNK
Bandhan Bank Limited
Announcement
EPACKPEB
EPack Prefab Technologies Limited
Announcement
View all today's announcements →
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when BLISSGVS files new disclosures
Track BLISSGVS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BLISSGVS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research